FindTrial
Sign In

Proportion of the arm lymphatic vessels above the axillary vein with implication in axillary dissection to preventing arm lymphedema: a prospective randomized controlled trial

Proportion of the arm lymphatic vessels above the axillary vein with implication in axillary dissection to preventing arm lymphedema: a prospective randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017858
Enrollment
Unknown
Registered
2018-08-17
Start date
2018-08-16
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

1:Proportion of the arm lymphatic vessels above the axillary vein with implication in axillary dissection
2:standard axillary dissection

Sponsors

Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. clinically node-positive breast cancer patients or clinically node-negative breast cancer patients with positive sentinel node; 2. patients without distant metastasis; 3. Patients agreed to participate in the study.

Exclusion criteria

Exclusion criteria: 1. patients with historical surgery in the ipsilateral axilla; 2. multifocal breast cancer patients; 3. pregnant patients; 4. allergic to iodine.

Design outcomes

Primary

MeasureTime frame
morbidity of arm lymphedema ;locoregional recurrence;—

Secondary

MeasureTime frame
disability of shoulder joint;Axillary seroma;Paresthesia;—

Countries

China

Contacts

Public ContactGaosong Wu

Zhongnan Hospital of Wuhan University

wugaosongtj@163.com+86 13871444606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026